| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 06/16/2011 | CA2783958A1 Oxazine derivative |
| 06/16/2011 | CA2783537A1 Benzamide compound |
| 06/15/2011 | EP2333093A1 Preparation of microbial oil containing polyunsaturated fatty acids |
| 06/15/2011 | EP2332978A1 Novel polypeptides involved in immune response |
| 06/15/2011 | EP2332976A1 Novel polypeptides involved in immune response |
| 06/15/2011 | EP2332974A2 Osteoprotegerin |
| 06/15/2011 | EP2332964A1 Apoptotically active peptides |
| 06/15/2011 | EP2332953A1 Substituted amine derivative and medicinal composition comprising same as the active ingredient |
| 06/15/2011 | EP2332952A1 Modified 2' and 3'-nucleoside prodrugs for treating flaviridae infections |
| 06/15/2011 | EP2332943A1 Novel fused aminodihydrothiazine derivative |
| 06/15/2011 | EP2332938A1 Viral inhibitors |
| 06/15/2011 | EP2332934A1 Chrystals including a malic acid salt of N-[2-(diethylamino)ethyl]-5-[(5-fluoro-1,2-dihydro-2-oxo-3h-indole-3-ylidene)methyl]-2,4-dimethyl-1h-pyrrole-3-carboxamide, processes for its preparation and compositions thereof |
| 06/15/2011 | EP2332932A1 Novel crystal forms of 4-(2-aminopyridin-4-yl)-3-(4 fluoro- phenyl)-1-(1,4,5,6-tetrahydro-6-oxopyridazin-3-yl)-1h-pyra-zole methanesulfonate and process for production of same |
| 06/15/2011 | EP2332924A1 Pyrimidine derivates, medicaments comprising them, their use and process of their preparation |
| 06/15/2011 | EP2332922A1 N-substituted azoles and their use as MEK-1 and/or ERK-2 modulators |
| 06/15/2011 | EP2332915A1 Beta2-adrenoceptor agonists |
| 06/15/2011 | EP2332581A1 Multivalent Meningococcal Polysaccharide-Protein Conjugate Vaccine |
| 06/15/2011 | EP2332580A1 A composition for the treatment of the central nervous system |
| 06/15/2011 | EP2332576A1 Immunotherapy of B-cell malignancies using anti-CD22 antibody conjugates |
| 06/15/2011 | EP2332563A2 Use of BAFF to treat sepsis |
| 06/15/2011 | EP2332561A1 Blockade of T lymphocyte down-regulation associated with CTLA-4 signaling |
| 06/15/2011 | EP2332553A1 Methods and compositions to treat myocardial conditions |
| 06/15/2011 | EP2332542A2 Use of methylol-containing compounds for the manufacture of a medicament for the treatment of tumors |
| 06/15/2011 | EP2332540A1 Administration of ranolazine for the treatment of diabetes |
| 06/15/2011 | EP2332539A1 Pharmaceutical preparation, food or beverage having inhibitory activity on serotonin transporter |
| 06/15/2011 | EP2332538A1 Combinations comprising a 4-isoquinolone derivative and anti-HIV agents |
| 06/15/2011 | EP2332531A1 Apo2 ligand/TRAIL formulations |
| 06/15/2011 | EP2332530A1 The use of potassium 2-( - hydroxypentyl) benzoate in the manufacture of medicaments for preventing and/or treating senile dementia |
| 06/15/2011 | EP2331138A1 Disulfide-linked polyethyleneglycol/peptide conjugates for the transfection of nucleic acids |
| 06/15/2011 | EP2144906B1 Heterocycles as orexin antagonists |
| 06/15/2011 | EP1717229B1 Novel cyclic compound having 4-pyridylalkylthio group having (un)substituted amino introduced therein |
| 06/15/2011 | EP1619185B1 4,4-difluoro-1,2,3,4-tetrahydro-5h-1-benzazepine derivative or salt thereof |
| 06/15/2011 | EP1417229B1 Methods and compounds for the targeting of protein to exosomes |
| 06/15/2011 | EP1389618B1 Pyrazolo 1,5-a pyridines and medicines containing the same |
| 06/15/2011 | EP1349558B1 Composition comprising melissa leaf extract for anti-angiogenic and matrix metalloproteinase inhibitory activity |
| 06/15/2011 | EP1213971B1 Improving condition of elderly pets |
| 06/15/2011 | EP1175400B1 Renin inhibitors |
| 06/15/2011 | EP1052254B1 Nitrogenous heterocyclic derivatives and medicine thereof |
| 06/15/2011 | CN1930145B Cycloalkanopyridine derivative |
| 06/15/2011 | CN1832948B 1- alkyl-1-azoniabicyclo (2.2.2) octane carbamate derivatives and their use as muscarinic receptor antagonists |
| 06/15/2011 | CN1820734B Treatment with anti-erbb2 antibodies |
| 06/15/2011 | CN102099467A SiRNA of human osteopontin |
| 06/15/2011 | CN102099354A Azole compound |
| 06/15/2011 | CN102099352A STAT3 inhibitor containing quinolinecarboxamide derivative as active ingredient |
| 06/15/2011 | CN102099039A Use of pyrimidylaminobenzamide derivatives for the treatment of fibrosis |
| 06/15/2011 | CN102099023A Agent for activating stem cells |
| 06/15/2011 | CN102093363A Pyrrolo-triazine aniline compounds useful as kinase inhibitors |
| 06/15/2011 | CN102093320A Soluble epoxide hydrolase inhibitor |
| 06/15/2011 | CN102091330A Pharmaceutical compositions comprising valsartan and NEP inhibitors |
| 06/15/2011 | CN102091304A Chinese medicine oral liquid with functions of restoring yang qi and dispelling cold and preparation method thereof |
| 06/15/2011 | CN102091230A Process for extraction and preparation of composition of Chinese date and manyflower solomonseal rhizome |
| 06/15/2011 | CN102091220A Traditional Chinese medicine for treating endogenous heat disease |
| 06/15/2011 | CN102091210A Traditional Chinese medicine soaking drink |
| 06/15/2011 | CN102091107A Method for extracting total triterpene of centella asiatica by enzymic process |
| 06/15/2011 | CN102090819A Far infrared anti-electromagnetic wave body-perfuming sleeping bag used for teenagers, comprising nano selenium and traditional Chinese medicinal materials and capable of generating negative ions |
| 06/15/2011 | CN102090636A PUFA supplements |
| 06/15/2011 | CN102090629A Dual-purpose food--medicament product capable of delaying aging and preparation method thereof |
| 06/15/2011 | CN101596191B Method for treatment of disease using malonyl-coa decarboxylase inhibitor |
| 06/15/2011 | CN101522194B Prophylactic/therapeutic agent for renal dysfunction |
| 06/15/2011 | CN101474360B Emergency compound Chinese herbal medicine for preventing and treating rabbit fever |
| 06/15/2011 | CN101469014B Novel compound and separation method thereof |
| 06/15/2011 | CN101417006B Preparation method of animal medicine capable of increasing animal immunity and reducing stress reaction |
| 06/15/2011 | CN101381366B Benzimidazole derivative and its use as a ii receptor antagonist |
| 06/15/2011 | CN101230067B Broadspectrum 2-(substituted-amino)-benzothiazole sulfonamide HIV protease inhibitors |
| 06/15/2011 | CN101094847B Aryloxy-substituted benzimidazole derivatives |
| 06/15/2011 | CN101056855B Nitrogenous heterocyclic derivative and medicine containing the same as an active ingredient |
| 06/15/2011 | CN101039678B Imidazo[1,5a]triazolo[1,5d]benzodiazepine derivatives for the treatment of cognitive disorders |
| 06/14/2011 | US7960579 2-amino-bicyclo [3.1.0] hexane-2,6-dicarboxylic ester derivative |
| 06/14/2011 | US7960570 Small molecule inhibitors of rotamase enzyme activity |
| 06/14/2011 | US7960525 Gene repair involving in vivo excision of targeting DNA |
| 06/14/2011 | US7960437 Improving aesthetic appearance of skin by reducing wrinkles and fine lines, improving smoothness, texture, firmness, moisture, elasticity and resilience; topical application of a mixture of a phtyol and a cyclic-AMP derivative |
| 06/14/2011 | US7960416 Oil-in-water emulsion of a 1-carboxylate-6-arylsulfamoyl cyclohexene and synthetic and naturally occurring phospholipids; nitric oxide or cytokine prodution inhibitors; cardiovascular disorders, autoimmune dieseases, septic shock; improved stability during autoclave sterilization |
| 06/14/2011 | US7960412 Selective estrogen receptor modulator |
| 06/14/2011 | US7960394 3,8-dimethyl-2-[4-(3-piperidin-1-ylpropoxy)phenyl]-4(3H)-quinazolinone; 6-chloro-3-methyl-2-[4-(3-piperidin-1-ylpropoxy)phenyl]pyrido[3,4-d]-pyrimidin-4(3H)-one; 2-[4-(1-cyclopentyl-4-piperidinyloxy)phenyl]-3-methylpyrido[2,3-d]-pyrimidin-4(3H)-one; treats metabolic, nervous system, vascular disorders |
| 06/14/2011 | US7960369 Receptor function regulator |
| 06/14/2011 | US7960367 Pregnane steroids and their use in the treatment of CNS disorders |
| 06/14/2011 | US7960366 Substituted tetracycline compounds as synergistic antifungal agents |
| 06/14/2011 | US7960361 Formulating an anti-cancer vaccine comprising an agent that can stimulate an immune response against IL-13R alpha 2 outside of the subject, and administering the vaccine to the subject |
| 06/14/2011 | US7960351 Method for producing pectin hydrolysis products |
| 06/14/2011 | US7960163 Matriptase, a serine protease and its applications |
| 06/14/2011 | US7960128 TRP8, a transient receptor potential channel expressed in taste receptor cells |
| 06/14/2011 | US7960127 Using channel protein to identify inhibitors of bitter and/or sweet taste preception |
| 06/14/2011 | US7959947 Film coating |
| 06/14/2011 | CA2566301C Novel use of peptide compounds for treating essential tremor and other tremor syndromes |
| 06/14/2011 | CA2494962C Tyrosine kinase inhibitors |
| 06/14/2011 | CA2484183C Methods and compositions for treating ectoparasite infestation |
| 06/14/2011 | CA2480987C Natural products and derivatives thereof for protection against neurodegenerative diseases |
| 06/14/2011 | CA2478232C Heterocyclic amide derivatives as cytokine inhibitors |
| 06/14/2011 | CA2476127C New pharmaceutical compositions based on anticholinergics and egfr kinase inhibitors |
| 06/14/2011 | CA2470037C Prodrugs to d-prolines |
| 06/14/2011 | CA2468704C Urea derivatives as angiogenesis inhibitors |
| 06/14/2011 | CA2452752C Dye-azide compounds for dual phototherapy |
| 06/14/2011 | CA2443325C Combination therapy comprising glucose reabsorption inhibitors and retinoid-x receptor modulators |
| 06/14/2011 | CA2437966C 4-fluoro-n-indan-2-yl benzamide and its use as pharmaceutical |
| 06/14/2011 | CA2433667C Prodrugs of excitatory amino acids |
| 06/14/2011 | CA2428468C New 7-azaindoles, their use as inhibitors of phosphodiesterase 4, and a method for synthesizing them |
| 06/14/2011 | CA2425311C Ketone compounds and compositions for cholesterol management and related uses |
| 06/14/2011 | CA2413313C Antitumor effect potentiators |
| 06/14/2011 | CA2337205C Treatment of skin disorders |
| 06/14/2011 | CA2200540C Use of l-carnitine or derivatives thereof and antioxidants for the prevention and treatment of diseases elicited by oxidative stress to the nervous and cardiovascular system |